1. Introduction {#sec0005}
===============

IgG antibodies are responsible for antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and complement activation, functions mediated through binding of the Fc region to Fcγ receptors and C1q, respectively. The Fc region comprises a dimer of C~H~2 and C~H~3 domains that are linked to the two Fab fragments through the hinge region, and an oligosaccharide moiety covalently attached to the C~H~2 domain at position 297. The typical pattern of glycosylation is that of a heptasaccharide bi-antennary core, which can additionally contain fucose, galactose and sialic acid residues ([@bib0160; @bib0165]). Altered IgG glycosylation plays a role in disease ([@bib0165]). For example agalactosylation is found in Crohn\'s disease and rheumatoid arthritis, where the level of galactosylation is negatively correlated with disease severity ([@bib0295; @bib0230]).

The oligosaccharide not only orients the C~H~2 domains ([@bib0190]) but affects Fcγ receptor binding and complement activation ([@bib0180; @bib0110; @bib0115]), and therefore plays an important role in influencing IgG effector function. Engineering the IgG-Fc oligosaccharide moiety is thus an attractive approach in the design of therapeutic monoclonal IgG antibodies ([@bib0015; @bib0165]).

Crystal structures have been solved for human IgG1-Fc containing the typical bi-antennary moiety (e.g. [@bib0150; @bib0215]), in addition to glycoforms modified through enzymatic activity or manipulation of the carbohydrate processing pathway ([@bib0190; @bib0065; @bib0035]). Crystal structures have also been solved for human IgG1-Fc and murine IgG1-Fc devoid of oligosaccharide ([@bib0105; @bib0030]; Braden, DOI:10.2210/pdb3dnk/pdb).

Recently, we reported the crystal structures of serum-derived and recombinant human IgG4-Fc, revealing structural features that could explain the unique, anti-inflammatory biological properties of IgG ([@bib0075]). We now report the crystal structure of enzymatically deglycosylated, serum-derived human IgG4-Fc (degly-Fc)\*, solved at 2.7 Å resolution.

The deglycosylated IgG4-Fc structure reveals two interlocked Fc molecules in a novel packing arrangement, with the C~H~2 domains oriented in a symmetric, open conformation. The part of the C~H~2 domain surface exposed by the absence of oligosaccharide is partially buried by intermolecular C~H~2-C~H~2 domain interactions. The degly-Fc structure also reveals conformational differences in functionally important loop regions. The structure of the C~H~2 DE loop, containing residue 297, is altered in the absence of oligosaccharide. The C~H~2 FG loop, which is involved in Fcγ receptor and C1q binding, adopts two different conformations. One conformation is unique to IgG4 and would disrupt Fcγ and C1q binding, while the second is similar to the conserved conformation found in IgG1, folded back on to the C~H~2 domain, suggesting that the IgG4 C~H~2 FG loop is dynamic. Recently, involvement of an IgG hexamer in the interaction with C1 was reported ([@bib0090]). Crystal packing in the degly-Fc structure reveals a hexameric arrangement of IgG4-Fc molecules that involves movement of the C~H~2 domain AB loop, providing further insight into the structural requirements for the IgG/C1q interaction.

2. Materials and methods {#sec0010}
========================

2.1. Protein preparation and crystallisation {#sec0015}
--------------------------------------------

Serum-derived, human IgG4-Fc (degly-Fc)\*, derived from the Rea IgG4 myeloma protein ([@bib0170]), was enzymatically deglycosylated as described previously ([@bib0135]). Crystals were grown at 291 K using a reservoir of 50 μL 100 mM Bis-Tris propane pH 7.5, 20% (w/v) PEG 3350 and 200 mM sodium citrate, and a drop size of 100 nL protein (6 mg/mL) and 200 nL reservoir. Crystals were harvested after 2 months and briefly cryoprotected in a solution of 100 mM Tris--HCl pH 7.0, 20% (w/v) PEG 3350, 200 mM sodium citrate, and 20% (v/v) glycerol before flash-cooling in liquid nitrogen.

2.2. Structure determination, model building and refinement {#sec0020}
-----------------------------------------------------------

Data were collected at beamline I04-1 at the Diamond Light Source (Harwell, UK). Integration was performed with XDS within the *xia2* package ([@bib0175; @bib0320]), and further processing was carried out using the CCP4 suite ([@bib0315]). The structure was solved by molecular replacement with MOLREP ([@bib0305]) using protein atoms from PDB accession number [4C54](pdb:4C54){#intr0045} ([@bib0075]). Refinement was performed with PHENIX ([@bib0020]) and manual model building with *Coot* ([@bib0095]). TLS groups were assigned with PHENIX. Overall structure quality was assessed with MolProbity ([@bib0055]) and POLYGON ([@bib0300]) within PHENIX. Buried surface areas were calculated with CNS ([@bib0040]). Data processing and refinement statistics are presented in [Table 1](#tbl0005){ref-type="table"}. Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 4D2N. Figures were produced with PyMOL (The PyMOL Molecular Graphics System, Version 1.1r1, Schrödinger, LLC). C~H~2 domain loops (AB, BC, DE and FG) are referred to in accordance with the C1-type immunoglobulin domain strand definition of [@bib0145].

3. Results and discussion {#sec0025}
=========================

3.1. Overall structure and molecular packing {#sec0030}
--------------------------------------------

The asymmetric unit of the deglycosylated IgG4-Fc (degly-Fc)\* structure contains two interlocked Fc molecules related to one another by a pseudo-symmetric two-fold rotation ([Fig. 1](#fig0005){ref-type="fig"}A). No interpretable electron density was present for residues preceding Gly236, Pro238, Gly237 or Leu235 for chains A, B, C and D, respectively. Superposition of IgG structures containing at least one intact hinge disulfide bond (e.g. [@bib0220]) on either molecule of the degly-Fc structure revealed atomic clashes between the hinge and the second interlocked molecule. Given the orientation of the two interlocked molecules, and that SDS-PAGE analysis of the degly-Fc protein revealed the hinge region was not intact in all Fc molecules in the sample (data not shown), it is possible that the species lacking an intact hinge was selectively crystallised.

The overall orientation of C~H~2 and C~H~3 domains is essentially identical for all four chains, which could be superposed with r.m.s. deviations of 0.39--0.90 Å. While there are local differences at the interfaces between the four chains of the degly-Fc asymmetric unit, some due to side chain disorder, the general features can be described as follows. The C~H~2 domain from chain A simultaneously contacts the C~H~2 domain from chain C and the C~H~3 domain from chain D. The overall molecular packing is such that C~H~2-C~H~2 and C~H~2-C~H~3 domain interactions for chain B are with chains D and C, those for chain C are with chains A and B, and those for chain D are with chains B and A, respectively, with an average buried surface area of 1470 Å^2^.

Because of some side chain disorder in chain A, a detailed description of the intermolecular C~H~2-C~H~2 and C~H~2-C~H~3 interfaces is presented from the perspective of chain B ([Fig. 1](#fig0005){ref-type="fig"}B): The C~H~2-C~H~2 domain interaction between chains B and D has pseudo two-fold symmetry, and comprises residues forming hydrogen bonds (Gln295 and Arg301), flanked by others forming van der Waals interactions (Phe243 and Phe296). The C~H~2-C~H~3 domain interface between chains B and C is formed predominantly from van der Waals interactions. This interface comprises C~H~2 domain FG loop residues Pro329 and Ser330 (chain B), and Lys340, Tyr373, Leu398 and Phe404 (chain C) ([Fig. 1](#fig0005){ref-type="fig"}B).

With the exception of conversion of Asn297 to Asp297 through the activity of PNGase F, and conformational differences in loop regions (described below), some due to the absence of oligosaccharide, there were no significant differences between the overall structure of deglycosylated IgG4-Fc and glycosylated IgG4-Fc ([@bib0075]).

3.2. C~H~2 domain surface {#sec0035}
-------------------------

IgG typically contains a heptasaccharide bi-antennary core, with additional fucose, galactose and sialic acid residues ([@bib0160]). The serum-derived Rea myeloma protein used for this study has a 70% G(0)\* (agalactosyl) oligosaccharide moiety ([@bib0170]), but was enzymatically deglycosylated ([@bib0135]), and thus no electron density was observed for any carbohydrate.

In glycosylated IgG4-Fc, the heptasaccharide core covers the surface of the C~H~2 domain, burying a total area of ∼1000 Å^2^. The patch exposed by the absence of carbohydrate in the degly-Fc structure is partially covered by the intermolecular C~H~2-C~H~2 domain interface, burying a total surface area of ∼750 Å^2^. While the surface buried by the C~H~2-C~H~2 domain interface is not identical to that buried by carbohydrate, residues Phe243 and Arg301 participate in both C~H~2-C~H~2 domain and C~H~2--carbohydrate interactions.

3.3. C~H~2 domain orientation {#sec0040}
-----------------------------

Deglycosylation of human IgG1-Fc from a decasaccharide (G2F)~2~\* moiety, to a tetrasaccharide (MN2F)~2~\* moiety, causes the C~H~2 domains to approach one another, and the distance between Pro329 Cα atoms, located at the top of the C~H~2 domains ([Fig. 2](#fig0010){ref-type="fig"}), decreases from 33.7 Å to 21.9 Å ([@bib0190]). The crystal structure of aglycosylated human IgG1-Fc (produced in *E. coli*) revealed an even more closed C~H~2-C~H~2 conformation, with Pro329-Pro329 Cα distances of 18.9 Å and 19.6 Å for the two Fc molecules of the asymmetric unit ([@bib0030]), while that of deglycosylated murine IgG1-Fc was most closed, with a distance of 11.6 Å ([@bib0105]) ([Fig. 2](#fig0010){ref-type="fig"}A). The top of one C~H~2 domain was partially disordered in the crystal structure of deglycosylated human IgG1-Fc, enzymatically treated to remove all but the first covalently attached N-acetylglucosamine moiety, but the C~H~2 domains also adopted a closed conformation; such closed conformations are incompatible with Fcγ receptor binding ([@bib0025]).

In contrast, a crystal structure of fully deglycosylated human IgG1-Fc revealed an open C~H~2 domain conformation, with a Pro329-Pro329 Cα distance of 27.6 Å, stabilised by crystal packing contacts with neighbouring Fc molecules (PDB accession number [3DNK](pdb:3DNK){#intr0055}, Braden, DOI:10.2210/pdb3dnk/pdb) ([Fig. 2](#fig0010){ref-type="fig"}B and C). The deglycosylated IgG4-Fc structure that we report here also adopts an open C~H~2 domain conformation, dictated by the interlocked nature of the Fc molecules in the asymmetric unit, with a Pro329-Pro329 Cα distance of 29.1 Å. This open conformation is similar to that found in the deglycosylated human IgG1-Fc structure ([Fig. 2](#fig0010){ref-type="fig"}B and C), and consistent with Small Angle X-ray Scattering (SAXS) studies, where in solution, unaffected by crystal packing, the Fc molecule adopts an open conformation in the absence of oligosaccharide ([@bib0030]).

3.4. C~H~2 domain DE loop {#sec0045}
-------------------------

The C~H~2 domain DE loop, which includes Asn297 to which the oligosaccharide is attached, displays a conserved conformation in glycosylated IgG-Fc structures. It is altered, however, in enzymatically deglycosylated ([@bib0105], Braden, DOI:10.2210/pdb3dnk/pdb) or aglycosylated ([@bib0030]) structures. In the degly-Fc structure, reported here, the conformation of the DE loop is similarly altered ([Fig. 3](#fig0015){ref-type="fig"}A). Asn297 is deamidated to Asp through the action of PNGase F, and in chains A, C and D, the Asp297 side chain adopts different rotamer positions compared with Asn297 in glycosylated IgG-Fc. Variation is also observed in the Asp297 and Ser298 Cα atom positions between the four chains of the degly-Fc asymmetric unit (up to a maximum of 1.8 Å), which both differ from their positions in glycosylated IgG-Fc (indicated by arrows in [Fig. 3](#fig0015){ref-type="fig"}A).

In IgG-Fc crystal structures, Tyr296 (IgG1) or Phe296 (IgG2 and IgG4) from the DE loop adopt a range of positions, pointing towards or away from the oligosaccharide, independent of the presence or absence of a fucose residue linked to the first N-acetylglucosamine. However, in degly-Fc, Phe296 faces towards the inner face of the C~H~2 domain in a manner that would not be possible in fucosylated IgG4-Fc due to steric clashes. Adoption of this conformer facilitates the formation of van der Waals contacts between the two interlocked Fc molecules of the degly-Fc asymmetric unit ([Fig. 3](#fig0015){ref-type="fig"}A).

3.5. C~H~3-C~H~3 interface {#sec0050}
--------------------------

IgG4 undergoes a process known as Fab-arm exchange, by which the heavy chains separate to form two half-molecules; these half-molecules can then recombine with other half molecules, to form bi-specific antibodies. Together with the hinge, which forms intra- rather than inter-heavy chain disulfide bonds, Arg409 from the C~H~3 domain plays a key role in controlling Fab-arm exchange (FAE) in IgG4 ([@bib0005; @bib0310; @bib0010; @bib0200; @bib0205; @bib0250; @bib0255]). Arg409 was recently reported to adopt two different conformations at the C~H~3-C~H~3 interface; one conformer weakens the C~H~3-C~H~3 interface and disrupts a conserved network of water molecules, while the other does not ([@bib0070; @bib0075]). In the degly-Fc structure, the conformer which weakens the C~H~3-C~H~3 interface was only observed in chain D, while chains A, B and C contain the second, non-disruptive conformer. The co-existence of these two different conformers within a single IgG4-Fc dimer has been observed in other IgG4-Fc crystal structures ([@bib0075]) and provides further evidence for the flexibility of this residue.

3.6. C~H~2 domain FG loop {#sec0055}
-------------------------

In IgG, the C~H~2 domain FG loop (residues 325--331) is important for both Fcγ receptor and C1q binding ([@bib0050; @bib0285; @bib0150]). In IgG1, the FG loop conformation is conserved, but in IgG4 it adopts a different, unique conformation, consistent with the anti-inflammatory properties of this subclass ([@bib0075]). In the glycosylated IgG4-Fc structure, the FG loop was unaffected by crystal packing and folded away from the C~H~2 domain; the different conformation was attributed to two sequence differences between IgG1 and IgG4, namely Ala327Gly and Pro331Ser. In contrast, the C~H~2 FG loop in chains A, B and D of the degly-Fc structure adopts a conformation which is similar to that found in IgG1, and folds back on to the C~H~2 domain. On the other hand, in chain C of the degly-Fc structure, although residues Lys326, Gly327 and the side chain of Leu328 are disordered, the positions of residues Pro329 and Ser330 are more akin to those of the unique IgG4 FG loop conformation.

In chains A, B and D the IgG1-like FG loop is stabilised by van der Waals crystal packing contacts, with C~H~3 domain residues from chains D, C and A, respectively ([Figs. 1B and 3B](#fig0005 fig0015){ref-type="fig"}). The part of the FG loop from chain C that is ordered is also stabilised by van der Waals interactions, but these are different from those for chains A, B and D. The two C~H~2 FG loop conformations observed in the degly-Fc structure demonstrate mobility of this loop in IgG4.

While the overall, conserved, conformation of the degly-Fc C~H~2 FG loop in chains A, B and D is similar to that for IgG1-Fc, the backbone atoms for residues 326--330 are shifted. In particular, compared with receptor-bound IgG1-Fc, the Cα position for Pro329 differs by ∼1.9 Å, and that for residue 327 (Gly in IgG1 and Ala in IgG1) differs by ∼1.6 Å, which would have the effect of moving the C~H~2 FG loop closer towards the Fcγ receptor ([Fig. 3](#fig0015){ref-type="fig"}C). This relatively small shift in loop position is sufficient to cause interatomic clashes, and would disrupt the "proline sandwich" interaction, formed between Pro329 from the FG loop and two Trp residues from the receptor ([@bib0275; @bib0235; @bib0110; @bib0220; @bib0245]).

A conserved, but shifted, C~H~2 FG loop is not unique to the degly-Fc structure as a similar perturbation is observed for IgG2, in which residue 327 is also Gly ([@bib0290]). Much smaller perturbations of the Pro329 position are found in IgG1-Fc (e.g. PDB accession number [3DO3](pdb:3DO3){#intr0060}, Braden, DOI:10.2210/pdb3do3/pdb), suggesting a role for Ala327 in positioning Pro329 for the IgG1/Fcγ interaction.

3.7. IgG4-Fc can assemble into an Fc-Fc mediated hexamer {#sec0060}
--------------------------------------------------------

The C1q component of complement has a hexameric arrangement, and activates the classical complement pathway through binding to IgM and IgG immune complexes ([@bib0045; @bib0130; @bib0125]). An IgM hexamer (or pentamer with J-chain) can activate complement ([@bib0240]). Recently, the involvement of IgG Fc-Fc mediated hexameric ring structures in the IgG1--Fc/C1 interaction was reported ([@bib0090]). Similar hexameric IgG Fc-Fc arrangements are found in two crystal structures of intact IgG antibodies (PDB accession number [1HZH](pdb:1HZH){#intr0065}, [@bib0260]; PDB accession number [4NHH](pdb:4NHH){#intr0070}; [@bib0325]). The degly-Fc crystals belong to a hitherto unreported space group for IgG-Fc (*P*622), although the same space group was reported for intact IgG4 crystals ([@bib0195]), and the six-fold crystallographic axis generates a hexameric, planar assembly of IgG4-Fc molecules, in which chain A from one Fc molecule interacts with chain B from another ([Fig. 4](#fig0020){ref-type="fig"}A).

The overall diameter of the IgG1 and IgG4 Fc hexameric rings, ∼175 Å, is similar to the diameter of the Cμ3-Cμ4 hexamer model for IgM (180 Å) ([@bib0225]). The IgG Fc-Fc interface involves C~H~3-C~H~3, C~H~3-C~H~2, and C~H~2-C~H~2 domain contacts ([Fig. 4](#fig0020){ref-type="fig"}B), perpendicular to the six-fold rotation axis and related by a two-fold rotation, burying a surface area of approximately 2150 Å^2^. A region located on the side of the Fc molecule, at the C~H~2-C~H~3 domain interface, is involved in *Staphylococcal* protein A, *Streptococcal* protein G, FcRn, HSV-1 (herpes simplex virus 1) Fc receptor, rheumatoid factor and TRIM21 (tripartite motif 21) binding ([@bib0080; @bib0265; @bib0060; @bib0085; @bib0210; @bib0280; @bib0155]). The same region facilitates other Fc--Fc interactions ([@bib0140; @bib0185; @bib0075]), and the hexamer interface is yet another to utilise this consensus site, indirectly exploited by the C1q interaction.

The degly-Fc structure and a structure of an intact IgG antibody, both solved at 2.7 Å resolution (PDB accession number [1HZH](pdb:1HZH){#intr0075}, [@bib0260]), now provide the highest resolution views of the IgG Fc-Fc hexamer interaction to date.

Residues involved in the IgG1 and IgG4 hexamer interfaces are identical. C~H~3-C~H~3 domain contact (shown in [Fig. 4](#fig0020){ref-type="fig"}B) includes hydrophobic interactions between His433^A^ (chain A) and Pro387^B^ (chain B), van der Waals interactions between Tyr436^A^ and Tyr436^B^, and hydrogen bonds between Asn434^A^, Glu380^B^ and Tyr436^B^, and between Gln438^A^ and Gln438^B^ (main chain). Ile253^A^ from the C~H~2 domain protrudes into a pocket created by Leu251^B^, Ile253^B^, His310^B^, Gln311^B^, Leu314^B^ (C~H~2 domain) and His435^B^ (C~H~3 domain). Additionally, His435^A^ from the C~H~3 domain forms van der Waals interactions with Ile253^B^ and Ser254^B^ from the C~H~2 domain. Met252 from the C~H~2 domain adopts different side chain positions, but forms van der Waals interactions with nearby residues, including Met428, Asn434 and His435.

3.8. The C~H~2 domain AB loop in the IgG hexamer {#sec0065}
------------------------------------------------

In IgG, the C~H~2 domains adopt a range of orientations in relation to the C~H~3 domains ([@bib0290; @bib0120]). In the degly-Fc structure, the C~H~2 domains for all chains (A--D) adopt an open conformation. Superposition of a number of IgG-Fc structures available from the Protein Data Bank onto the degly-Fc hexamer (formed by chains A and B) using C~H~3 domain Cα atoms revealed clashes between residues from the C~H~2 domain AB loop. Even superposition of chains C and D from the degly-Fc structure revealed clashes, implying that a structural change within the C~H~2 domain is required to form the hexamer.

Further structural comparison, involving superposition of C~H~2 domains onto the degly-Fc hexamer, revealed close contacts mediated by Ile253 from the C~H~2 AB loop in the vast majority of structures analysed, including close contacts between Ile253^A^ and Ile253^B^ and Ile253^A^ and His310^B^, where A and B refer to interfacing chains ([Fig. 4](#fig0020){ref-type="fig"}B). Thus, to form the hexamer interface, a structural change occurs in the C~H~2 AB loop, in which residues Ile253 and Ser254 move away from the C~H~2 domain. A similar loop movement is required to form both IgG1 and IgG4 hexamers, for example the Ile253 Cα atom moves 1.37 Å in IgG1 and 1.14 Å in IgG4, while the Ser254 Cα atom moves 1.53 Å (IgG1) and 1.21 Å (IgG4) ([Fig. 5](#fig0025){ref-type="fig"}).

3.9. Implications for C1q binding {#sec0070}
---------------------------------

In human IgG1, residues Asp270, Lys322, Pro329 and Pro331 are important for C1q binding ([@bib0285; @bib0150]) (indicated in red on the degly-Fc hexamer in [Fig. 4](#fig0020){ref-type="fig"}A; residue 331 is Ser in IgG4). In IgG4, the C~H~2 domain BC and FG loops can adopt a different conformation, disrupting the binding site ([@bib0075]). Formation of an IgG4 hexamer suggests that the inability of IgG4 to activate complement is the result of local structural differences in the C~H~2 domain, although the degly-Fc structure presented here does reveal a dynamic FG loop with the ability to adopt the conserved, IgG1-like conformation.

The effect of a recently described Glu345Arg mutation in enhancing complement activation ([@bib0090]) can now be rationalised through the formation of a hydrogen bond between Arg345 and the Gly385 main chain or Gln386 side chain, presumably creating a more stable hexamer. It is intriguing that this mutation increases complement activation in all IgG subclasses, suggesting that interactions at the hexamer interface are able to compensate for structural differences in the C~H~2 domain.

While residues at the IgG1 and IgG4 hexamer interfaces are identical, the interactions formed are not. For example, in both IgG1 and IgG4, variation in the Met252 side chain position is observed. Furthermore, while similar, the IgG1 and IgG4 hexamers are not identical when superposed. In a number of IgG3 allotypes, Arg435 and Phe436 replace His and Tyr, found in IgG1 and IgG4, respectively. Since these residues are both at the interface, allotypic sequence differences and variation in side chain position could affect the orientation of Fc molecules within the hexamer, which in turn might alter the disposition of the C1q binding sites, and the molecular surface presented to C1.

4. Conclusions {#sec0075}
==============

In summary, we solved the structure of enzymatically deglycosylated, serum-derived human IgG4-Fc at 2.7 Å resolution. The structure comprises a novel, interlocked arrangement of two Fc molecules and reveals structural alteration of the C~H~2 DE loop in the absence of carbohydrate. Furthermore, the C~H~2 FG loop adopts two different conformations, one unique to IgG4, and one more akin to the conserved conformation found in IgG1. Finally, crystal packing reveals a hexameric arrangement of Fc molecules, similar to the IgG1 hexamer involved in C1 binding. The deglycosylated IgG4-Fc structure reported here thus extends our understanding of this structurally less well characterised IgG subclass.

We thank Marty Rajaratnam (King\'s College London) for the X-ray facility, 104-1 beamline staff for data collection assistance at the Diamond Light Source, UK, and Rosy Calvert (King\'s College London) and Anthony Keeble (King\'s College London) for helpful discussions. AMD is funded by the Medical Research Council, UK (grant number G1100090). We acknowledge Diamond Light Source for time on Beamline I04-1 under Proposal mx7656.

![Overall structure. (A) The two interlocked Fc molecules of the asymmetric unit (blue and pink) are shown, centred on the intermolecular C~H~2-C~H~2 interaction between chains B and D. The overall packing is such that intermolecular C~H~2-C~H~2 and C~H~2-C~H~3 interactions for chain A are with chains C and D, chain B with chains D and C, chain C with chains A and B, and chain D with chains B and A, respectively. (B) Detailed view of the interaction between chains B, C and D. C~H~2-C~H~2 contacts are formed between chains B and D by residues Phe243, Gln295, Phe296 and Arg301. C~H~2-C~H~3 contacts are formed between chains B and C, respectively, by residues Pro329, Ser330, Tyr373, Leu398 and Phe404. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr1){#fig0005}

![C~H~2 domain orientation. (A) View down the IgG-Fc pseudo two-fold axis with the C~H~2 domains in the foreground. The deglycosylated murine IgG1-Fc structure (PDB accession number [3HKF](pdb:3HKF){#intr0005}; [@bib0105]) (pink), and the Pro329 Cα atom interatomic distance (11.6 Å) indicate a closed conformation. The C~H~2 domains in the degly-Fc structure (green) adopt a more open conformation. The two Fc structures were superposed on the C~H~3 domains. (B) The deglycosylated human IgG1-Fc structure (PDB accession number [3DNK](pdb:3DNK){#intr0010}, Braden, DOI:10.2210/pdb3dnk/pdb) (blue), and the Pro329-Pro329 Cα atom interatomic distance (27.6 Å) reveals a more open conformation, similar to that for the degly-Fc structure (green). (C) Front view of the degly-Fc structure (green) and deglycosylated human IgG1-Fc structure (blue). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr2){#fig0010}

![C~H~2 domain DE and FG loops. (A) The DE loop is shown for glycosylated IgG1-Fc (white) (PDB accession number [3AVE](pdb:3AVE){#intr0015}; [@bib0215]) and glycosylated IgG4-Fc (green) (PDB accession number [4C54](pdb:4C54){#intr0020}; [@bib0075]). For both glycosylated structures, the fucose residue, and the first N-acetyl glucosamine residue to which it is attached, is shown. Chains A (yellow), B (pink) and C (blue) from the degly-Fc structure are shown. The positions of the Cα atoms for residues 297 and 298 are indicated with arrows. The conformation adopted by Phe296 in molecules B and C from the degly-Fc structure clashes with the fucose residue, in contrast to the conformation adopted by Phe296 from glycosylated IgG4-Fc and Tyr296 from glycosylated IgG1-Fc, which does not. (B) The FG loop is shown for glycoslated IgG4-Fc, glycosylated IgG1-Fc and chains A-C from the degly-Fc structure. The FG loop for chains A and B from the degly-Fc structure (pink, yellow) adopt a similar conformation to the conserved loop conformation found in IgG1-Fc (white). The FG loop from molecule C (dark blue) is partially disordered, but the ordered residues adopt a similar conformation to that found in glycosylated IgG4-Fc (light blue). (C) The "proline sandwich" interaction between IgG-Fc and FcγRIII. The C~H~2 FG loop from IgG1-Fc (white) interacts with the Fcγ receptor (white), and the proline sandwich comprises Pro329 (IgG1-Fc) flanked by Trp90 and Trp113 (FcγRIII) (PDB accession number [3AY4](pdb:3AY4){#intr0025}; [@bib0220]). The C~H~2 FG loop is shown for chains A (yellow) and B (pink) from the degly-Fc structure. While the loop adopts a similar overall conformation to that in IgG1-Fc, the position of Pro329 is shifted in a manner that would clash with the receptor. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr3){#fig0015}

![Crystallographic symmetry generates a hexameric assembly of Fc molecules. (A) Overall structure of the degly-Fc hexamer, 175 Å in diameter. Individual Fc molecules of the hexamer are coloured separately. Asp270, Lys322, Pro329 and Ser331 (Pro331 in IgG1) are coloured red, according to a model of the IgG-Fc/C1q interaction ([@bib0270]). The C~H~2 domain FG loop adopts the conserved, IgG1-like conformation, compatible with C1q binding. (B) The Fc-Fc hexamer interface between chains A and B from adjacent Fc molecules, comprising residues from both C~H~2 and C~H~3 domains. The chain A Ile253 Cδ atom was not built in the degly-Fc structure, and in this figure, the same side chain rotamer observed in chain B was modelled. Chain A carbon atoms are coloured white, and chain B carbon atoms pink. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr4){#fig0020}

![C~H~2 domain AB loop movement in hexamer formation. Ile253 and Ser254 from the C~H~2 AB loop move to accommodate formation of the IgG hexamer. The arrow close to Ile253 indicates the direction of movement. The AB loop is shown for IgG1-Fc (white) (PDB accession number [3AVE](pdb:3AVE){#intr0030}; [@bib0215]), glycosylated IgG4-Fc (green) (PDB accession number [4C54](pdb:4C54){#intr0035}; [@bib0075]), chain B of the degly-Fc structure (pink) and intact IgG1 (blue) (PDB accession number [1HZH](pdb:1HZH){#intr0040}, [@bib0260]). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr5){#fig0025}
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Data processing and refinement statistics.

  Data processing                                                 
  --------------------------------------------------------------- --------------------------------------------------------------
  Space group                                                     *P*622
  Unit cell dimensions                                            
   *a*, *b*, *c* (Å)                                              196.95, 196.95, 96.96
  Resolution (Å)                                                  53.68--2.70 (2.83--2.70)[a](#tblfn0005){ref-type="table-fn"}
  No. of unique reflections[b](#tblfn0010){ref-type="table-fn"}   30 902 (4 012)[a](#tblfn0005){ref-type="table-fn"}
  Completeness (%)[b](#tblfn0010){ref-type="table-fn"}            99.9 (99.9)[a](#tblfn0005){ref-type="table-fn"}
  Redundancy[b](#tblfn0010){ref-type="table-fn"}                  20.0 (20.0)[a](#tblfn0005){ref-type="table-fn"}
  Mean ((*I*)/σ(*I*)) [b](#tblfn0010){ref-type="table-fn"}        16.9 (1.6)[a](#tblfn0005){ref-type="table-fn"}
  *R*~pim~ (%)[b](#tblfn0010){ref-type="table-fn"}                4.0 (61.2) [a](#tblfn0005){ref-type="table-fn"}
  Wilson *B* factor (Å^2^)                                        64.7

  Refinement                                              
  ------------------------------------------------------- ---------------------
  *R*~work~/*R*~free~ (%)                                 20.45/25.44
  RMSD                                                    
   Bond lengths (Å)                                       0.002
   Bond angles (°)                                        0.603
   Coordinate error (Å)                                   0.38
  No. of atoms                                            
   Protein                                                6310
   Solvent                                                12
   Other[d](#tblfn0020){ref-type="table-fn"}              6
  Ave. *B* factor (Å^2^)                                  
   Protein: C~H~2 A/B/C/D                                 81.8/84.5/92.6/87.8
   Protein: C~H~3 A/B/C/D                                 56.8/56.9/73.8/79.8
   Solvent                                                54.9
   Other[d](#tblfn0020){ref-type="table-fn"}              91.0
  Ramachandran plot[c](#tblfn0015){ref-type="table-fn"}   
   Favoured (%)                                           98.3
   Allowed (%)                                            100

Numbers in parentheses are for the highest resolution shell.

Data scaled with Aimless ([@bib0315; @bib0100]).

Ramachandran plot generated by MolProbity ([@bib0055]).

Glycerol.
